wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33836107-DA71CCFD-E22C-48E0-96A6-A886B9C4937C
Q33836107-DA71CCFD-E22C-48E0-96A6-A886B9C4937C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33836107-DA71CCFD-E22C-48E0-96A6-A886B9C4937C
Best hope or last hope: access to phase III clinical trials of HER-2/neu for advanced stage breast cancer patients.
P2860
Q33836107-DA71CCFD-E22C-48E0-96A6-A886B9C4937C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33836107-DA71CCFD-E22C-48E0-96A6-A886B9C4937C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a81e8f722bae67e3bcc261efa530df77aa1fab1d
P2860
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).